Bausch + Lomb (BLCO) free cash flow

Free cash flow · fiscal 2025
-$66.00M

Bausch + Lomb (BLCO) generated free cash flow of -$66.00M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$59.00M. Figures as of 18 Nov 2026, 12:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$66.00M
Highest on record
$680.00Mfiscal 2021
Lowest on record
-$198.00Mfiscal 2023
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bausch + Lomb free cash flow, in more detail

Across the 6 fiscal years on record (2020–2025), the highest was $680.00M in fiscal 2021 and the lowest -$198.00M in fiscal 2023.

History · 6 fiscal years

Free cash flow by fiscal year

Bausch + Lomb free cash flow, year by year

Bausch + Lomb (BLCO) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$66.00M—
2024-$59.00M—
2023-$198.00M 216.5% down
2022$170.00M 75.0% down
2021$680.00M 152.8% up
2020$269.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Bausch + Lomb and comparable companies
CompanyFree cash flowFiscal year
ImmunityBio IBRX-$309.19M2025
Cytokinetics CYTK-$534.82M2025
ABIVAX ABVX-€161.27M2025
Bausch + Lomb BLCO-$66.00M2025
Amneal Pharmaceuticals AMRX$225.64M2025
Caris Life Sciences CAI$66.90M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BLCO

Bausch + Lomb, figure by figure

Bausch + Lomb (BLCO) overview: price, valuation and scorecardAll health care companies by market value

Bausch + Lomb free cash flow: questions and answers

What is Bausch + Lomb's free cash flow?

Bausch + Lomb (BLCO) generated free cash flow of -$66.00M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$59.00M.

What are the highest and lowest free cash flow figures on record for Bausch + Lomb?

Across the 6 fiscal years on record (2020–2025), the highest was $680.00M in fiscal 2021 and the lowest -$198.00M in fiscal 2023.

How is Bausch + Lomb's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Bausch + Lomb it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bausch + Lomb (BLCO) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/BLCO/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.